Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
Improved overall survival and three-year relapse-free survival seen with blinatumomab plus chemo for adult patients
FDA Approves Another Blood Test for Colon Cancer Screening
Prostate Cancer Outcomes Comparable for Transgender Women, Cisgender Men
No significant associations seen between transgender identity and metastatic presentation, high-risk localized disease
Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
Recipients receiving cells from donors in lowest quartile of SES experienced reduction in overall survival, increase in treatment-linked mortality
Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle Cell
For girls with sickle cell disease, density of growing follicles was marginally lower in hydroxyurea group after adjustment for age
Nudge in EHR Can Reduce Unnecessary Sentinel Lymph Node Biopsy
Reduction in rate of SLNB among women meeting Choosing Wisely criteria for omission of SLNB
Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer
Greatest reduction seen for women aged 65 to 74 years who self-identify as Black
Disparities Persist in Postmastectomy Reconstruction
American Indian/Alaska Native women remain 38 percent less likely to receive postmastectomy reconstruction than White women
Chemo Tied to Gut Microbiome Changes and Associated Cognitive Decline
Findings independent of chemotherapy-induced inflammation
Many Breast Cancer Survivors With Indications for Genetic Testing Do Not Receive It
Findings not just following diagnosis, but six years after diagnosis
